<html>
<head>
<title>Dati Finanziari per AstraZeneca PLC</title>
</head>
<body>
<h1>Dati finanziari per: AstraZeneca PLC (AZN.L)</h1>
<img src="https://i.postimg.cc/gjn0wqqF/Senza-nome-275.png" alt="AstraZeneca PLC logo" style="width:100px;height:auto;"/>
<p>AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company that is a global leader in biopharmaceutical innovation. The company's primary focus lies in three core therapy areas: Oncology, Rare Diseases (strengthened by the acquisition of Alexion), and BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism, and Respiratory & Immunology). AstraZeneca is renowned for its robust R&D pipeline and its commitment to precision medicine and data-driven drug discovery. A major player in global health, the company maintains extensive manufacturing facilities and research centers worldwide, focusing on life-changing medicines that address complex unmet medical needs. Its corporate headquarters are located in Cambridge, United Kingdom.</p>
<table border='1'>
<tr>
<th>Data</th>
<th>Apertura</th>
<th>Chiusura</th>
<th>Massimo</th>
<th>Minimo</th>
<th>Volume</th>
<th>Cambiamento</th>
</tr>
<tr>
<td>2025-12-19</td>
<td>10850.00</td>
<td>10945.00</td>
<td>11020.00</td>
<td>10820.00</td>
<td>1980600</td>
<td>+95.00</td>
</tr>
</table>
</body>
</html>
